DLA Piper acted as US counsel to Zealand Pharma on the offering. Zealand Pharma, a Danish biotechnology company focused on the discovery and development of peptide-based...
Zealand Pharma’s US$1 Billion Equity Offering
Zealand Pharma’s €90 Million Financing Agreement with EIB
Plesner advised Zealand Pharma on the deal. NASDAQ Copenhagen-listed biotech Zealand Pharma, signed a finance contract agreement with The European Investment Bank concerning a EUR 90 million term...
Zealand Pharma A/S’ DKK 1.5 Billion Shares Private Placement
Kromann Reumert has assisted the Managers in the placement: Danske Bank, Goldman Sachs, Jefferies, Nordea and Van Lanschot Kempen. The biotechnology company Zealand Pharma A/S has...
Zealand Pharma’s DKK 786 Million Shares Private Placement
Kromann Reumert has assisted Danske Bank A/S, Goldman Sachs International and Nordea Danmark, Filial af Nordea Bank Abp, Finland, which acted as Joint Global Coordinators and...